Hong Kong Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HONG KONG, and what generic and branded alternatives to HONG KONG drugs are available?
HONG KONG has three approved drugs.
Drugs and US Patents for Hong Kong
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hong Kong | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 213599-001 | May 9, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hong Kong | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 040557-002 | Feb 23, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hong Kong | MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 076553-001 | Jul 28, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.